Singapore-based ChemLex raised a $45M funding round led by Granite Asia to build an AI-powered, automated chemistry lab to accelerate drug discovery (Rachyl Jones/Semafor)
PositiveArtificial Intelligence
- Singapore-based ChemLex has successfully raised $45 million in a funding round led by Granite Asia, aimed at developing an AI-powered automated chemistry lab to enhance drug discovery processes. This initiative seeks to streamline and accelerate the development of new therapies through advanced technology.
- The funding is crucial for ChemLex as it positions the company at the forefront of innovation in the pharmaceutical industry, potentially transforming how drugs are discovered and developed. The automated lab is expected to significantly reduce the time and costs associated with traditional drug discovery methods.
- This development reflects a growing trend in the Asia-Pacific region, where significant investments in AI and technology are being made to foster advancements across various sectors, including healthcare. The establishment of ChemLex's lab aligns with broader efforts by companies like Google DeepMind, which is also investing in AI research in Singapore, indicating a robust ecosystem for technological innovation in the region.
— via World Pulse Now AI Editorial System
